SCHEMBL31646830

SCHEMBL31646830

CC(c1ccccc1)N1CCN(c2cncc(Cl)n2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.54
ALDH1A1 P00352 3/20 0.49
KDM4E B2RXH2 3/20 0.49
HTR2A P28223 2/20 0.49
HPGD P15428 2/20 0.49
MEN1 O00255 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
HTR1A P08908 1/20 0.49
CYP2C9 P11712 1/20 0.49
HTR2C P28335 1/20 0.49
CYP2C19 P33261 1/20 0.49
KMT2A Q03164 1/20 0.49
HSD17B10 Q99714 1/20 0.49
MC4R P32245 1/20 0.49
DRD2 P14416 1/20 0.48
HRH1 P35367 1/20 0.48
TRPC5 Q9UL62 1/20 0.44
OGA O60502 4/20 0.42
AURKA O14965 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15332863 0.81 HTR2A (0.58) ALDH1A1KDM4EHTR2AHPGDMEN1
SCHEMBL31647228 0.79 CYP2D6 (0.51) CYP2D6ALDH1A1KDM4EHPGDMC4R
SCHEMBL19461216 0.78 OGA (0.71) OGA
SCHEMBL4994102 0.78 HTR2A (0.58) ALDH1A1KDM4EHTR2AHPGDMEN1
SCHEMBL31647002 0.76 CYP2D6 (0.51) CYP2D6ALDH1A1KDM4EHTR2AMEN1
SCHEMBL3366951 0.76 HTR2A (0.53) CYP2D6ALDH1A1KDM4EHTR2AHPGD
SCHEMBL31646972 0.76 OGA (0.64) CYP2D6ALDH1A1KDM4EHPGDMC4R
SCHEMBL31647041 0.75 CYP2D6 (0.53) CYP2D6ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL16226061 0.73 CYP2D6 (1.00) CYP2D6ALDH1A1HTR2ACYP1A2CYP3A4
SCHEMBL6706135 0.73 CYP2D6 (1.00) CYP2D6ALDH1A1HTR2ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025137146-A1 SUBSTITUTED HETEROARYL ANALOGS AND USES THEREOF FOR THE TREATMENT OF HIV-ASSOCIATED NEUROCOGNITIVE DISORDERS MOUKHA CHAFIQ OMAR (US) 2025-06-26 WO disclosed